Latest:
Unmet Needs and Future Direction in HER2+ Breast Cancer
The panel looks to the future landscape for HER2+ breast cancer, highlighting emerging treatment practices and currently unmet needs.
Authors
Horacio J. Asbun, MD
Latest:
Mapping Progress in Pancreatic Cancer Surgery: Leveraging New Technology
In this last episode of OncChats: Mapping Progress Made in Pancreatic Cancer Surgery, Horacio J. Asbun, MD, and Domenech Asbun, MD, explain how augmented reality or artificial intelligence may be utilized to improve outcomes for patients with pancreatic cancer who are undergoing surgical procedures.
Jacqueline Aredo, MD, MS
Latest:
Dr Aredo on the Molecular Distribution of Screening-Eligible Patients With NSCLC
Jacqueline Aredo, MD, MS, discusses findings from a study assessing the molecular distribution of driver mutations and tumor suppressor gene mutations in patients with non–small cell lung cancer who are eligible for lung cancer screening.
Marco Davila, MD, PhD
Marco Davila, MD, PhD, the senior vice president and associate director for Translational Research in the Department of Medicine, as well as the Rustum Family Endowed Chair in Translational Research at Roswell Park Comprehensive Cancer Center
Latest:
Dr Davila on the Future Use of Biomarkers to Predict CAR T-Cell Therapy Resistance in LBCL
Marco Davila, MD, PhD, discusses how a study of tumor drivers of CAR T-cell therapy resistance in LBCL may promote future biomarker investigations.
Kami J. Maddocks, MD
Kami J. Maddocks, MD, is a hematologist at The Ohio State University Comprehensive Cancer Center—James
Latest:
Mantle Cell Lymphoma: Evolving Strategies in Diagnosis & Treatment
Kami J. Maddocks, MD; and Morgane Cheminant, MD, PhD, discuss evolving strategies in the diagnosis and treatment of mantle cell lymphoma.